Homocitrulline-d₃

Homocitrulline-d₃ is intended for use as an internal standard for the quantification of homocitrulline (Item No. 34980) by GC- or LC-MS. Homocitrulline is an amino acid and a product of carbamylation, a post-translational modification of proteins and amino acids.^1,2 It is formed by the adduction of isocyanic acid, a product of urea degradation or thiocyanate oxidation induced by myeloperoxidase (MPO), to the ε-amino group of lysine residues.² Protein-bound homocitrulline levels are increased in the aortas of transgenic Ldlr^-/- mice expressing human MPO fed a high-fat atherogenic diet.³ Intra-articular injection of homocitrulline-containing peptides induces the development of arthritis in mice.⁴ Homocitrulline-containing peptide and anti-homocitrulline antibody levels are increased in whole blood from patients with erosive rheumatoid arthritis compared to patients with non-erosive rheumatoid arthritis.

WARNING This product is not for human or veterinary use.

1. Shi, J., Knevel, R., Suwannalai, P., et al. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc. Natl. Acad. Sci. USA 108(42), 17372-17377 (2011).

2. Verbrugge, F.H., Tang, W.H.W., and Hazen, S.L. Protein carbamylation and cardiovascular disease. Kidney Int. 88(3), 474-478 (2015).

3. Wang, Z., Nicholls, S.J., Rodriquez, E.R., et al. Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat. Med. 13(1), 1176-1184 (2007).

4. Mydel, P., Wang, Z., Brisslert, M., et al. Carbamylation-dependent activation of T cells: A novel mechanism in the pathogenesis of autoimmune arthritis. J. Immunol. 184(12), 6882-6890 (2010).